FDA Inspection
e+ OncoLogics Louisiana, LLCe+ OncoLogics Louisiana, LLC – FDA Inspection, Jul 9, 2024
Record Details
This FDA Inspection record concerns e+ OncoLogics Louisiana, LLC, with an inspection on July 9, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 8c5ba84c-740c-47d1-b0bc-813b41d85a52
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1245125
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of e+ OncoLogics Louisiana, LLC
7| Date | Classification | Office | Project area |
|---|---|---|---|
| March 28, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| January 18, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 21, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 15, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 31, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for e+ OncoLogics Louisiana, LLC
- FDA Inspection 1171284 - 2022-03-28
- FDA Inspection 1046033 - 2018-01-18
- FDA Inspection 977278 - 2016-07-21
- FDA Inspection 907097 - 2014-12-15
- FDA Inspection 833821 - 2013-05-31
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.